EP Patent

EP0552612A2 — Methods for determining and isolating compounds which bind directly to nucleosolic proteins

Assigned to F Hoffmann La Roche AG · Expires 1993-07-28 · 33y expired

What this patent protects

Methods for determining and isolating ligands resulting from compounds which produce binding with nucleosolic proteins are described.

USPTO Abstract

Methods for determining and isolating ligands resulting from compounds which produce binding with nucleosolic proteins are described.

Drugs covered by this patent

minocycline-hydrochloride (MINOCYCLINE HYDROCHLORIDE)

Patent Metadata

Patent number: EP0552612A2
Jurisdiction: EP
Classification: —
Expires: 1993-07-28
Drug substance claim: No
Drug product claim: No
Assignee: F Hoffmann La Roche AG
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.